KANDAVE Trademark

Trademark Overview


On Thursday, April 30, 2015, a trademark application was filed for KANDAVE with the United States Patent and Trademark Office. The USPTO has given the KANDAVE trademark a serial number of 86614951. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 13, 2022. This trademark is owned by Glaxo Group Limited. The KANDAVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kandave

General Information


Serial Number86614951
Word MarkKANDAVE
Filing DateThursday, April 30, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 13, 2022
Registration Number4846065
Registration DateTuesday, November 3, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkKAN DAVE: CAN DAVE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, May 13, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, November 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 3, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 18, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 30, 2015ASSIGNED TO EXAMINER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 12, 2015NOTICE OF PSEUDO MARK E-MAILED
Monday, May 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 4, 2015NEW APPLICATION ENTERED IN TRAM